camptothecin has been researched along with Sclerosis, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barusińska, A; Czuwara, J; Jabłonska, S; Makieła, B; Nowicka, U; Rudnicka, L | 1 |
| Avalos-Diaz, E; Herrera-Esparza, R; Lopez-Swiderski, A; Ramirez-Santoyo, R | 1 |
| Czuwara-Ladykowska, J; Makiela, B; Rudnicka, L; Smith, EA; Trojanowska, M | 1 |
3 other study(ies) available for camptothecin and Sclerosis, Systemic
| Article | Year |
|---|---|
Implications for the use of topoisomerase I inhibitors in treatment of patients with systemic sclerosis.
Topics: Camptothecin; Collagen; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Scleroderma, Systemic; Skin; Topoisomerase I Inhibitors | 1996 |
The expression and localization of Scl-70/DNA topoisomerase I vary throughout the cell cycle.
Topics: Antineoplastic Agents, Phytogenic; Autoantigens; Blotting, Western; Camptothecin; Cell Cycle; Cell Division; DNA Replication; DNA Topoisomerases, Type I; Fluorescent Antibody Technique, Indirect; Humans; Hydroxyurea; Mitotic Index; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; S Phase; Scleroderma, Systemic; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1998 |
The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis.
Topics: Adult; Camptothecin; Cells, Cultured; Collagen; Culture Media, Conditioned; Dose-Response Relationship, Drug; Elastin; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Female; Fibroblasts; Humans; Male; Procollagen; RNA, Messenger; Scleroderma, Systemic; Skin; Topoisomerase I Inhibitors | 2001 |